The “medication first” era of glaucoma treatment is over. This presentation provides a brief update on early-line Interventional Glaucoma techniques before reviewing a series of recent high-quality publications that will influence our ongoing use of micro-invasive glaucoma surgery (MIGS), tube shunts, and trabeculectomy. Finally, it provides an advanced look at genetic testing and the use of AI in glaucoma diagnosis, management, and patient education; emerging topics that are likely to take the spotlight in the coming years.
Over 1300 attended our event and we received amazing feedback!
Feedback from anonymous survey:
Dr. Garza was an exceptional speaker! Bravo!
Love the glaucoma series! Please do another one later in the year.
Great food for thought on where glaucoma management is going!
This was an AWESOME lecture! Would love to attend more of this speaker’s lectures.
Very good presentation. Discusses professions working together.
I appreciate the medical topics. Thank you!
One of the best lectures yet. Thank you so much for this. Excellent excellent excellent!
I really enjoyed the lecture with Dr. Garza! I learned so much about the future of glaucoma.
Great Glaucoma updates. Keep having more Glaucoma CE!
Very Informative presentation!!!
Speaker: Philip Garza, MD
Moderator: Dr. Carolyn Majcher
COPE ID: 98104-GL
Category: Glaucoma
This event is COPE approved for 1 hour of CE credit.
Thank you to Alcon, Thea Pharmaceuticals, and Zeiss for providing an educational grant for this series.
Thank you to Glaukos for exhibiting at this event.